ChemoMetec revenue and financials
In the fiscal year ended June 2026, ChemoMetec reported revenue of kr 511.06M (+3.12% year over year). Net income was kr 201.84M, a net margin of 39.5%.
Fiscal year ending in June. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +3.12%
- FY to Jun 2026 vs FY to Jun 2025
- Net income growth
- +15.53%
- FY to Jun 2026 vs FY to Jun 2025
- Net margin
- 39.5%
- FY to Jun 2025: 35.3%
How ChemoMetec is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 12.7% a year on average over the last 5 years
Compound annual growth rate: from kr 281.13M in 2021 to kr 511.06M in 2026.
Operating margin fell from 51.9% to 49.1%
Operating income over revenue, 2023 → 2026: 2.8 percentage points.
Profits turn into cash: free cash flow equal to 91% of net income
Totals for fiscal years 2024–2026: free cash flow kr 467.68M, net income kr 512.82M.
Financial data
Amounts in millions of DKK; per-share values in DKK; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 | FY to Jun 2021 | FY to Jun 2020 | FY to Jun 2019 | FY to Jun 2018 | FY to Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 511 | 496 | 408 | 444 | 428 | 281 | 214 | 176 | 113 | 90.3 |
| Cost of revenue | 25.1 | 30.1 | 40.3 | 32.9 | 44.1 | 27.8 | 20.2 | 16.9 | 13.2 | 10.1 |
| Gross profit | 486 | 466 | 368 | 412 | 384 | 253 | 194 | 159 | 99.5 | 80.2 |
| Selling, general and administrative | 205 | 207 | 181 | 160 | 161 | 118 | 97.3 | 93.7 | 69.4 | 64.3 |
| Operating income | 251 | 237 | 169 | 231 | 203 | 116 | 81.5 | 54.1 | 24.3 | 10.4 |
| EBIT | 251 | 237 | 169 | 231 | 203 | 116 | 81.5 | 54.1 | 24.3 | 10.4 |
| EBITDA | 266 | 248 | 179 | 244 | 217 | 129 | 91.9 | 61.2 | 28.4 | 13.2 |
| Interest expense | 0.4 | 0.6 | 0.2 | 1.1 | 1.5 | 0.9 | 1.2 | 0.7 | 0.9 | 1.1 |
| Pre-tax income | 258 | 225 | 177 | 230 | 203 | 113 | 75.9 | 53.7 | 23.3 | 8.7 |
| Income tax | 56.3 | 50.3 | 40.3 | 51.7 | 43.8 | 24.4 | 16.8 | 11.9 | 5.1 | 1.2 |
| Net income | 202 | 175 | 136 | 179 | 159 | 88.4 | 59.2 | 41.8 | 18.2 | 7.5 |
| Net income to common shareholders | 202 | 175 | 136 | 179 | 159 | 88.4 | 59.2 | 41.8 | 18.2 | 7.5 |
| Basic EPS | 11.60 | 10.04 | 7.83 | 10.27 | 9.16 | 5.08 | 3.51 | 2.69 | 1.17 | 0.48 |
| Diluted EPS | 11.60 | 10.04 | 7.83 | 10.27 | 9.16 | 5.08 | 3.51 | 2.69 | 1.17 | 0.48 |
| Average shares (basic) | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 16.9 | 15.6 | 15.5 | 15.7 |
| Average shares (diluted) | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 16.9 | 15.6 | 15.5 | 15.7 |
| Dividend per share | — | 7.00 | 4.00 | 6.00 | — | 4.00 | 1.50 | 7.50 | — | — |
Amounts in millions of DKK; per-share values in DKK; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 262 | 249 | 244 | 251 | 208 | 200 | 202 | 243 | 219 | 210 |
| Cost of revenue | 12.2 | 12.8 | 9.1 | 20.9 | 20.1 | 20.2 | 11.2 | 21.8 | 16.0 | 28.1 |
| Gross profit | 250 | 236 | 235 | 231 | 188 | 180 | 191 | 221 | 203 | 182 |
| Selling, general and administrative | 105 | 100 | 112 | 95.3 | 94.9 | 86.6 | 84.8 | 75.7 | 95.6 | 65.8 |
| Operating income | 130 | 121 | 110 | 126 | 84.3 | 84.6 | 95.8 | 135 | 96.6 | 106 |
| EBIT | 130 | 121 | 110 | 126 | 84.3 | 84.6 | 95.8 | 135 | 96.6 | 106 |
| EBITDA | 138 | 127 | 117 | 131 | 89.0 | 89.8 | 102 | 142 | 104 | 113 |
| Interest expense | — | 1.1 | 1.5 | 0.3 | — | 1.8 | 0.2 | 0.9 | 0.7 | 0.8 |
| Pre-tax income | 137 | 121 | 92.2 | 133 | 87.6 | 89.0 | 94.4 | 136 | 94.1 | 109 |
| Income tax | 28.8 | 27.5 | 20.8 | 29.5 | 21.8 | 18.5 | 21.2 | 30.5 | 19.8 | 23.9 |
| Net income | 108 | 94.0 | 71.3 | 103 | 65.7 | 70.6 | 73.2 | 105 | 74.3 | 85.2 |
| Net income to common shareholders | 108 | 94.0 | 71.3 | 103 | 65.7 | 70.6 | 73.2 | 105 | 74.3 | 85.2 |
| Basic EPS | 6.20 | 5.40 | 4.10 | 5.94 | 3.78 | 4.05 | 4.21 | 6.06 | 4.26 | 4.90 |
| Diluted EPS | 6.20 | 5.40 | 4.10 | 5.94 | 3.78 | 4.05 | 4.21 | 6.06 | 4.26 | 4.90 |
| Average shares (basic) | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 |
| Average shares (diluted) | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 | 17.4 |
Amounts in millions of DKK; per-share values in DKK; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 | FY to Jun 2021 | FY to Jun 2020 | FY to Jun 2019 | FY to Jun 2018 | FY to Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 861 | 839 | 677 | 658 | 501 | 345 | 263 | 238 | 114 | 97.6 |
| Current assets | 525 | 555 | 490 | 493 | 353 | 244 | 168 | 155 | 46.8 | 41.0 |
| Cash and equivalents | 290 | 342 | 296 | 317 | 209 | 150 | 96.9 | 98.2 | 9.8 | 12.4 |
| Short-term investments | 3.4 | — | — | — | — | — | — | — | — | — |
| Receivables | 99.2 | 85.9 | 69.1 | 59.7 | 69.5 | 64.1 | 46.2 | 37.1 | 20.2 | 15.3 |
| Inventory | 126 | 121 | 119 | 113 | 66.8 | 30.1 | 25.1 | 19.5 | 16.8 | 13.3 |
| Net property, plant and equipment | 127 | 116 | 92.0 | 82.7 | 74.8 | 42.5 | 43.4 | 38.1 | 28.9 | 26.4 |
| Goodwill | 7.4 | 7.4 | 0.0 | — | — | — | — | — | — | — |
| Other intangible assets | 201 | 146 | 94.5 | 79.7 | 67.4 | 57.9 | 51.4 | 45.1 | 38.2 | 30.0 |
| Current liabilities | 128 | 144 | 98.5 | 119 | 137 | 72.0 | 47.7 | 55.0 | 17.9 | 21.1 |
| Accounts payable | 38.1 | 16.1 | 11.1 | 17.6 | 17.0 | 8.7 | 8.4 | 9.7 | 7.3 | 4.9 |
| Long-term debt | — | — | — | — | — | — | — | — | 17.8 | 10.9 |
| Total debt | 4.6 | 6.4 | 4.2 | 7.2 | 6.8 | 2.4 | 2.3 | 18.8 | 20.1 | 21.9 |
| Total liabilities | 136 | 151 | 111 | 125 | 144 | 79.9 | 60.4 | 64.9 | 41.0 | 33.2 |
| Total equity (incl. minority) | 725 | 688 | 565 | 533 | 357 | 265 | 203 | 173 | 73.0 | 64.4 |
| Retained earnings | 733 | 653 | 548 | 516 | 340 | 248 | 185 | 156 | 55.2 | 46.6 |
Amounts in millions of DKK; per-share values in DKK; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 861 | 783 | 839 | 730 | 677 | 594 | 658 | 557 | 501 | 371 |
| Current assets | 525 | 484 | 555 | 491 | 490 | 421 | 493 | 398 | 353 | 239 |
| Cash and equivalents | 290 | 275 | 342 | 265 | 296 | 232 | 317 | 224 | 209 | 115 |
| Short-term investments | 3.4 | — | — | — | — | — | — | — | — | — |
| Receivables | 99.2 | 98.0 | 85.9 | 88.9 | 69.1 | 67.3 | 59.7 | 77.6 | 69.5 | 78.2 |
| Inventory | 126 | 107 | 121 | 133 | 119 | 118 | 113 | 92.9 | 66.8 | 45.6 |
| Net property, plant and equipment | 127 | 120 | 116 | 105 | 92.0 | 85.2 | 82.7 | 84.0 | 74.8 | 69.8 |
| Goodwill | 7.4 | 7.4 | 7.4 | 7.4 | — | — | — | — | — | — |
| Other intangible assets | 201 | 161 | 146 | 126 | 94.5 | 87.2 | 79.7 | 74.1 | 67.4 | 62.6 |
| Current liabilities | 128 | 123 | 144 | 123 | 98.5 | 89.9 | 119 | 91.7 | 137 | 77.5 |
| Accounts payable | 38.1 | 13.7 | 16.1 | 18.4 | 11.1 | 11.6 | 17.6 | 12.7 | 17.0 | 11.5 |
| Total debt | 4.6 | 5.2 | 6.4 | 7.8 | 4.2 | 5.9 | 7.2 | 7.9 | 6.8 | 6.0 |
| Total liabilities | 136 | 131 | 151 | 132 | 111 | 94.8 | 125 | 99.5 | 144 | 88.6 |
| Total equity (incl. minority) | 725 | 653 | 688 | 598 | 565 | 499 | 533 | 457 | 357 | 283 |
| Retained earnings | 733 | 637 | 653 | 581 | 548 | 481 | 516 | 440 | 340 | 265 |
Amounts in millions of DKK; per-share values in DKK; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 | FY to Jun 2021 | FY to Jun 2020 | FY to Jun 2019 | FY to Jun 2018 | FY to Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 210 | 207 | 129 | 154 | 177 | 108 | 72.0 | 58.3 | 25.4 | 9.8 |
| Depreciation and amortization | 14.9 | 11.2 | 9.8 | 13.9 | 13.8 | 13.0 | 10.5 | 7.1 | 4.1 | 2.8 |
| Capital expenditure | -28.3 | -29.9 | -20.9 | -21.2 | -39.1 | -11.2 | -14.3 | -15.2 | -5.5 | -3.0 |
| Investing cash flow | -99.8 | -85.5 | -43.5 | -40.8 | -56.0 | -24.7 | -26.6 | -27.1 | -16.5 | -10.3 |
| Financing cash flow | -162 | -75.0 | -106 | -2.9 | -69.0 | -26.0 | -46.3 | 57.8 | -7.9 | -0.4 |
| Dividends paid | -122 | -69.6 | -104 | — | -69.6 | -26.1 | -357 | — | — | — |
| Share repurchases | -38.6 | — | — | — | — | — | — | — | -9.6 | — |
| Debt issued | 0.6 | 0.5 | 0.3 | — | 0.4 | 0.9 | 2.7 | 1.0 | 2.8 | — |
| Debt repaid | -0.3 | -5.9 | -1.6 | -2.9 | -1.7 | -0.9 | -19.2 | -1.7 | -1.2 | -0.4 |
| Effect of exchange rates | -0.7 | -1.3 | -0.2 | -2.8 | 7.1 | -4.0 | -0.4 | -0.0 | -0.1 | -0.8 |
| Net change in cash | -51.7 | 45.7 | -20.4 | 108 | 58.9 | 53.2 | -1.3 | 89.0 | 0.9 | -1.7 |
| Free cash flow | 182 | 178 | 108 | 133 | 138 | — | — | — | — | — |
| Levered free cash flow | 57.4 | 130 | 41.3 | 71.0 | 105 | 67.1 | 34.6 | 17.6 | 0.5 | -4.2 |
Amounts in millions of DKK; per-share values in DKK; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 120 | 90.6 | 119 | 88.0 | 88.2 | 40.8 | 106 | 48.2 | 110 | 67.1 |
| Depreciation and amortization | 8.0 | 6.9 | 6.2 | 5.0 | 4.7 | 5.1 | 6.6 | 7.3 | 7.3 | 6.5 |
| Capital expenditure | -17.0 | -11.3 | -19.5 | -10.4 | -13.7 | -7.3 | -7.5 | -13.7 | -5.9 | -33.2 |
| Investing cash flow | -64.2 | -35.5 | -41.8 | -43.7 | -25.0 | -18.5 | -16.8 | -24.0 | -14.4 | -41.7 |
| Financing cash flow | -40.0 | -122 | 1.3 | -76.3 | 0.3 | -106 | -1.4 | -1.5 | -2.8 | -66.2 |
| Dividends paid | 0.0 | -122 | 0.0 | -69.6 | 0.0 | -104 | — | — | 0.0 | -69.6 |
| Share repurchases | -38.6 | — | — | — | — | — | — | — | — | — |
| Debt issued | 0.1 | 0.5 | 0.5 | — | 0.1 | 0.2 | — | — | -3.8 | 4.3 |
| Debt repaid | 0.0 | -0.3 | 0.8 | -6.7 | -0.3 | -1.3 | -1.4 | -1.5 | -0.9 | -0.9 |
| Effect of exchange rates | -0.0 | -0.7 | -1.9 | 0.6 | 0.5 | -0.8 | 2.0 | -4.9 | 1.7 | 5.4 |
| Net change in cash | 15.5 | -67.2 | 77.1 | -31.4 | 64.0 | -84.4 | 92.1 | 15.4 | 94.3 | -35.4 |
| Free cash flow | 103 | 79.3 | 99.9 | 77.7 | 74.5 | 33.5 | 98.4 | 34.6 | 104 | 33.8 |
| Levered free cash flow | 9.6 | 47.8 | 61.0 | 69.1 | 29.8 | 11.5 | 78.0 | -7.0 | 96.5 | 8.8 |
Financial statements of similar companies
Companies in the group: same industry, similar size
